Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study

Authors: Mekdes K Gebremariam, Gunnar A Bjune, Jan C Frich

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

Tuberculosis is a major public health problem in Ethiopia, and a high number of TB patients are co-infected with HIV. There is a need for more knowledge about factors influencing treatment adherence in co-infected patients on concomitant treatment. The aim of the present study is to explore patients' and health care professionals' views about barriers and facilitators to TB treatment adherence in TB/HIV co-infected patients on concomitant treatment for TB and HIV.

Methods

Qualitative study using in-depth interviews with 15 TB/HIV co-infected patients and 9 health professionals and focus group discussions with 14 co-infected patients.

Results

We found that interplay of factors is involved in the decision making about medication intake. Factors that influenced adherence to TB treatment positively were beliefs in the curability of TB, beliefs in the severity of TB in the presence of HIV infection and support from families and health professionals. Barriers to treatment adherence were experiencing side effects, pill burden, economic constraints, lack of food, stigma with lack of disclosure, and lack of adequate communication with health professionals.

Conclusion

Health professionals and policy makers should be aware of factors influencing TB treatment in TB/HIV co-infected patients on concomitant treatment for TB and HIV. Our results suggest that provision of food and minimal financial support might facilitate adherence. Counseling might also facilitate adherence, in particular for those who start ART in the early phases of TB treatment, and beliefs related to side-effects and pill burden should be addressed. Information to the public may reduce TB and HIV related stigma.
Literature
1.
World Health Organization: Global Tuberculosis Control: surveillance, planning, financing. 2008, Geneva: World Health Organization
2.
Federal Ministry of Health of Ethiopia: Manual for tuberculosis, leprosy and TB/HIV prevention and control program. 2008, Addis Ababa: Federal Ministry of Health
3.
Corbett EL, Marston B, Churchyard GJ, De Cock KM: Tuberculosis in Sub-Saharan Africa: opportunities, challenges and changes in the era of antiretroviral treatment. Lancet. 2006, 367: 926-937. 10.1016/S0140-6736(06)68383-9.CrossRefPubMed
4.
Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL: Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy. AIDS. 2002, 16: 75-83. 10.1097/00002030-200201040-00010.CrossRefPubMed
5.
Kwara A, Flanigan TP, Carter EJ: Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status. Int J Tuberc Lung Dis. 2005, 9: 248-257.PubMed
6.
Breen RA, Miller RF, Gorsuch T, Smith CJ, Schwenk A, Holmes W, Ballinger J, Swaden L, Johnson MA, Cropley I, Lipman MC: Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax. 2006, 6: 791-794. 10.1136/thx.2006.058867.CrossRef
7.
Aaron L, Saadoun D, Calatroni I, Launay O, Mémain N, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O: Tuberculosis in HIV infected patients: a comprehensive review. Clin Microbiol Infect. 2004, 10: 388-398. 10.1111/j.1469-0691.2004.00758.x.CrossRefPubMed
8.
Ingersoll KS, Cohen J: The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008, 31: 213-224. 10.1007/s10865-007-9147-y.CrossRefPubMedPubMedCentral
9.
Claxton AJ, Cramer J, Pierce C: A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001, 23: 1296-1310. 10.1016/S0149-2918(01)80109-0.CrossRefPubMed
10.
Richter A, Anton SE, Koch P, Dennett SL: The impact of reducing dose frequency on health outcomes. Clin Ther. 2003, 25: 2307-2335. 10.1016/S0149-2918(03)80222-9.CrossRefPubMed
11.
Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J: Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007, 4: e238-10.1371/journal.pmed.0040238.CrossRefPubMedPubMedCentral
12.
Shargie EB, Lindtjørn B: Determinants of treatment adherence among smear positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med. 2007, 4: e37-10.1371/journal.pmed.0040037.CrossRefPubMedPubMedCentral
13.
14.
Farmer P: Social scientists and the new tuberculosis. Soc Sci Med. 1997, 44: 347-358. 10.1016/S0277-9536(96)00143-8.CrossRefPubMed
15.
Chesney MA, Morin M, Sherr L: Adherence to HIV combination therapy. Soc Sci Med. 2000, 50: 1599-1605. 10.1016/S0277-9536(99)00468-2.CrossRefPubMed
16.
Demissie M, Kebede D: Defaulting from tuberculosis treatment at the Addis Abeba Tuberculosis Centre and factors associated with it. Ethiop Med J. 1994, 32: 97-106.PubMed
17.
Getahun H, Aragaw D: Tuberculosis in rural northwest Ethiopia: community perspective. Ethiop Med J. 2001, 39: 283-291.PubMed
18.
Tekle B, Mariam DH, Ali A: Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 2002, 6: 573-579.PubMed
19.
Shargie EB, Lindtjørn B: Determinants of treatment adherence among smear positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med. 2007, 4: e37-10.1371/journal.pmed.0040037.CrossRefPubMedPubMedCentral
20.
Michael KW, Belachew T, Jira C: Tuberculosis defaulters from the "dots" regimen in Jimma zone, southwest Ethiopia. Ethiop Med J. 2004, 42: 247-253.PubMed
21.
Getahun H, Maher D: Contribution of "TB clubs" to tuberculosis control in a rural district in Ethiopia. Int J Tuberc Lung Dis. 2000, 4: 174-178.PubMed
22.
Demissie M, Getahun H, Lindtjorn B: Community tuberculosis care through "TB clubs" in rural north Ethiopia. Soc Sci Med. 2003, 56: 2009-2018. 10.1016/S0277-9536(02)00182-X.CrossRefPubMed
23.
Sagbakken M, Frich JC, Bjune G: Barriers and enablers in the management of tuberculosis treatment in Addis-Ababa, Ethiopia: a qualitative study. BMC Public Health. 2008, 8: 11-10.1186/1471-2458-8-11.CrossRefPubMedPubMedCentral
24.
Addis Ababa Health Bureau: Strategic plan of Addis-Ababa City Administration Health Bureau 2004-2007. 2007, Addis Ababa: Addis Ababa Health Bureau
25.
Federal Ministry of Health, Federal HIV/AIDS Prevention and Control Office: Guidelines For implementation of the antiretroviral therapy programme in Ethiopia. 2007, Addis Ababa: Federal Ministry of Health
26.
Cummings KM, Becker MH, Maile MC: Bringing the models together: an empirical approach to combining variables used to explain health actions. J Behav Med. 1980, 3: 123-145. 10.1007/BF00844986.CrossRefPubMed
27.
Noyes J, Popay J: Directly observed therapy and tuberculosis: how can a systematic review of qualitative research contribute to improving services?. J Adv Nurs. 2007, 57: 227-243. 10.1111/j.1365-2648.2006.04092.x.CrossRefPubMed
28.
Malterud K: Shared understanding of the qualitative research process. Guidelines for the medical researcher. Fam Pract. 1993, 10: 201-206. 10.1093/fampra/10.2.201.CrossRefPubMed
29.
Liefooghe R, Baliddawa JB, Kipruto EM, Vermeire C, De Munynck AO: From their own perspective. A Kenyan community's perception of tuberculosis. Trop Med Int Health. 1997, 2: 809-821. 10.1046/j.1365-3156.1997.d01-380.x.CrossRefPubMed
30.
Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM: Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?. Int J Tuberc Lung Dis. 2005, 9: 263-269.PubMed
31.
Edginton ME, Sekatane CS, Goldstein SJ: Patients' beliefs: do they affect tuberculosis control? A study in a rural district of South Africa. Int J Tuberc Lung Dis. 2002, 6: 1075-1082.PubMed
32.
Mehta S, Moore RD, Graham NM: Potential factors affecting adherence with HIV therapy. AIDS. 1997, 11: 1665-1670. 10.1097/00002030-199714000-00002.CrossRefPubMed
33.
Chesney M: Adherence to HAART regimens. AIDS Patient Care STDS. 2003, 17: 169-177. 10.1089/108729103321619773.CrossRefPubMed
34.
Rocha M, Pereira S, Ferreira L, Barros H: The role of adherence in tuberculosis HIV positive patients treated in ambulatory regimen. Eur Respir J. 2003, 21: 785-788. 10.1183/09031936.03.00077302.CrossRefPubMed
35.
Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P: Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai Thailand. AIDS. 1997, 11: 107-112. 10.1097/00002030-199701000-00016.CrossRefPubMed
36.
Wares DF, Singh S, Acharya AK, Dangi R: Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal. Int J Tuberc Lung Dis. 2003, 7: 327-335.PubMed
37.
Kaona FA, Tuba M, Siziva S, Sikaona L: An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004, 4: 68-10.1186/1471-2458-4-68.CrossRefPubMedPubMedCentral
38.
Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007, 19: 658-665. 10.1080/09540120701244943.CrossRefPubMed
39.
Federal Ministry of Health, Federal HIV/AIDS Prevention and Control Office: Guidelines for Management of Opportunistic Infections and Antiretroviral Treatment in Adolescents and Adults in Ethiopia. 2007, Federal Ministry of Health
40.
Corbett EL, Marston B, Churchyard GJ, De Cock KM: Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006, 367: 926-937. 10.1016/S0140-6736(06)68383-9.CrossRefPubMed
41.
Ngamvithayapong J, Winkvist A, Diwan V: High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand. AIDS. 2000, 14: 1413-1419. 10.1097/00002030-200007070-00015.CrossRefPubMed
42.
Daniel OJ, Alausa OK: Treatment outcome of TB/HIV positive and TB/HIV negative patients on directly observed treatment, short course (DOTS) in Sagamu, Nigeria. Niger J Med. 2006, 15: 222-226.PubMed
43.
Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007, CD003343-
Metadata
Title
Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study
Authors
Mekdes K Gebremariam
Gunnar A Bjune
Jan C Frich
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-651

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue

Research article

Diagnostic efficiency of abattoir meat inspection service in Ethiopia to detect carcasses infected with Mycobacterium bovis: Implications for public health

Research article

Knowledge, attitudes and practices towards pandemic influenza among cases, close contacts, and healthcare workers in tropical Singapore: a cross-sectional survey

Research article

Inequitable walking conditions among older people: examining the interrelationship of neighbourhood socio-economic status and urban form using a comparative case study

Research article

Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic

Debate

To what extent could performance-based schemes help increase the effectiveness of prevention of mother-to-child transmission of HIV (PMTCT) programs in resource-limited settings? a summary of the published evidence

Research article

Legionella spp. and legionellosis in southeastern Italy: disease epidemiology and environmental surveillance in community and health care facilities